{"meta":{"status":{"id":200,"message":"OK"},"notes":"","fields":["document_id","document_version","document_display_id","title","publication_number","effective_date","effective_end_date","implementation_date","qr_modifier_date","benefit_category","item_service_description","indications_limitations","cross_reference","transmittal_number","transmittal_url","revision_history","other_text","ama_statement","reasons_for_denial"],"children":["/data/ncd/related-ncas?ncdid=136\u0026ver=1","/data/ncd/related-cals?ncdid=136\u0026ver=1","/data/ncd/related-cpis?ncdid=136\u0026ver=1","/data/ncd/other-versions?ncdid=136"],"next_token":""},"data":[{"document_id":"136","document_version":1,"document_display_id":"80.1","title":"Hydrophilic Contact Lens For Corneal Bandage","publication_number":"100-3","effective_date":"This is a longstanding national coverage determination. The effective date of this version has not been posted.","effective_end_date":"N/A","implementation_date":"","qr_modifier_date":"","benefit_category":"Incident to a physician\u0027s professional Service, Outpatient Hospital Services Incident to a Physician\u0027s Service","item_service_description":"\u0026lt;p\u0026gt;    Some hydrophilic contact lenses are used as moist corneal bandages for the treatment of acute or chronic corneal pathology, such as bullous keratopathy, dry eyes, corneal ulcers and erosion, keratitis, corneal edema, descemetocele, corneal ectasis, Mooren\u0026#39;s ulcer, anterior corneal dystrophy, neurotrophic keratoconjunctivitis, and for other therapeutic reasons.\u0026lt;\u0026sol;p\u0026gt;","indications_limitations":"\u0026lt;p\u0026gt;Payment may be made under \u0026amp;sect;1861(s)(2) of the Social Security Act for a hydrophilic contact lens approved by the Food and Drug Administration (FDA) and used as a supply incident to a physician\u2019s service. Payment for the lens is included in the payment for the physician\u2019s service to which the lens is incident.  Medicare Administrative Contractors are authorized to accept an FDA letter of approval or other FDA published material as evidence of FDA approval. (See \u0026amp;sect;80.4 for coverage of a hydrophilic contact lens as a prosthetic device.)\u0026lt;\u0026sol;p\u0026gt;","cross_reference":"See the \u0026lt;a href=\u0026quot;https:\u0026sol;\u0026sol;www.cms.gov\u0026sol;Regulations-and-Guidance\u0026sol;Guidance\u0026sol;Manuals\u0026sol;Internet-Only-Manuals-IOMs-Items\u0026sol;CMS012673\u0026quot;\u0026gt;Medicare Benefit Policy Manual\u0026lt;\u0026sol;a\u0026gt;, Chapter 15, \u201CCovered Medical and Other Health Services,\u201D and the \u0026lt;a href=\u0026quot;https:\u0026sol;\u0026sol;www.cms.gov\u0026sol;Regulations-and-Guidance\u0026sol;Guidance\u0026sol;Manuals\u0026sol;Internet-Only-Manuals-IOMs-Items\u0026sol;CMS012673\u0026quot;\u0026gt;Medicare Benefit Policy Manual\u0026lt;\u0026sol;a\u0026gt;, Chapter 6, \u201CHospital Services Covered Under Part B,\u201D \u0026#167;20.4","transmittal_number":"73","transmittal_url":"","revision_history":"\u0026lt;p\u0026gt;    12\u0026sol;1994 - Explained how payment\u0026amp;#160;provided when hydrophilic contact lenses are furnished incident to\u0026amp;#160;physician\u0026#39;s services. Effective date NA. (TN 73)\u0026lt;\u0026sol;p\u0026gt;","other_text":"","ama_statement":"","reasons_for_denial":""}]}